Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001091818-24-000134
Filing Date
2024-11-08
Accepted
2024-11-08 11:34:25
Documents
37
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 QTR. REPORT - SEPT. 2024 bfnh20240930_10q.htm   iXBRL 10-Q 296887
2 CHIEF EXECUTIVE OFFICER CERTIFICATION ex311.htm EX-31.1 4733
3 CHIEF FINANCIAL OFFICER CERTIFICATION ex312.htm EX-31.2 4976
4 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 ex321.htm EX-32.1 2078
5 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 ex322.htm EX-32.2 1989
11 GRAPHIC bfnhlogo2019001.jpg GRAPHIC 21193
  Complete submission text file 0001091818-24-000134.txt   1687146

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE bfnh-20240930.xsd EX-101.SCH 11176
7 XBRL CALCULATION FILE bfnh-20240930_cal.xml EX-101.CAL 18796
8 XBRL DEFINITION FILE bfnh-20240930_def.xml EX-101.DEF 22699
9 XBRL LABEL FILE bfnh-20240930_lab.xml EX-101.LAB 149713
10 XBRL PRESENTATION FILE bfnh-20240930_pre.xml EX-101.PRE 111107
39 EXTRACTED XBRL INSTANCE DOCUMENT bfnh20240930_10q_htm.xml XML 102311
Mailing Address 2020 GENERAL BOOTH BLVD SUITE 230 VIRGINIA BEACH VA 23454
Business Address 2020 GENERAL BOOTH BLVD SUITE 230 VIRGINIA BEACH VA 23454 757-306-6090
BIOFORCE NANOSCIENCES HOLDINGS, INC. (Filer) CIK: 0001310488 (see all company filings)

EIN.: 852138858 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51074 | Film No.: 241438812
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)